Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 20Terminated 3Unknown 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Anxiety Disorders 2Vulvar Neoplasms 1Vaginal Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Stage IB Cervical Cancer FIGO 2018 1Squamous Cell Carcinoma of Head and Neck 1Pulmonary Disease, Chronic Obstructive 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Hematologic Neoplasms 1Genital Neoplasms, Female 1Fatigue 1Endometrial Neoplasms 1Cancer Survivor 1Breast Neoplasms 1

Interventions

Cisplatin 9pembrolizumab 7Radiosurgery 6Gemcitabine 6Paclitaxel 5Dexamethasone 5Taxes 4Carboplatin 4trametinib 3ibrutinib 3Surveys and Questionnaires 3Standard of Care 3Radiotherapy 3Nivolumab 3Magnetic Resonance Spectroscopy 3Lenalidomide 3Fluorouracil 3Erlotinib Hydrochloride 3Blood Specimen Collection 3Ascorbic Acid 3venetoclax 2veliparib 2tocilizumab 2pazopanib 2obinutuzumab 2naquotinib 2lenvatinib 2fludarabine 2enzalutamide 2Vemurafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neoplasms × Educational Status × Clear all
NCT01828502 2014-10-29

Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer

University of South Florida

Phase 2 Withdrawn
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡